127 related articles for article (PubMed ID: 27834470)
1. Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.
Porcaro AB; Novella G; de Luyk N; Corsi P; Cacciamani G; Sebben M; Tafuri A; Processali T; Cerasuolo M; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 Sep; 103(5):475-482. PubMed ID: 27834470
[TBL] [Abstract][Full Text] [Related]
2. Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set.
Porcaro AB; Corsi P; de Luyk N; Sebben M; Tafuri A; Bizzotto L; Cacciamani G; De Marchi D; Processali T; Mattevi D; Novella G; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 Jul; 103(4):374-379. PubMed ID: 28291903
[TBL] [Abstract][Full Text] [Related]
3. Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer.
Porcaro AB; Novella G; Molinari A; Terrin A; Minja A; De Marco V; Martignoni G; Brunelli M; Cerruto MA; Curti P; Cavalleri S; Artibani W
Urol Int; 2015; 94(3):270-85. PubMed ID: 25170543
[TBL] [Abstract][Full Text] [Related]
4. Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.
Porcaro AB; Mattevi D; Novella G; De Luyk N; Corsi P; Bizzotto L; De Marchi D; Sebben M; Tafuri A; Inverardi D; Processali T; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Curr Urol; 2018 Feb; 11(2):85-91. PubMed ID: 29593467
[TBL] [Abstract][Full Text] [Related]
5. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
6. Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.
Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Panunzio A; De Michele M; Brunelli M; Cerruto MA; Migliorini F; Siracusano S; Artibani W
Urol Int; 2019; 103(4):415-422. PubMed ID: 31466070
[TBL] [Abstract][Full Text] [Related]
7. Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set.
Porcaro AB; Tafuri A; Novella G; Sebben M; Mariotto A; Inverardi D; Corsi P; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Brunelli M; Balzarro M; Siracusano S; Artibani W
Urol Int; 2018; 100(4):456-462. PubMed ID: 29672311
[TBL] [Abstract][Full Text] [Related]
8. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
9. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
[TBL] [Abstract][Full Text] [Related]
10. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
García-Cruz E; Carrión Puig A; García-Larrosa A; Sallent A; Castañeda-Argáiz R; Piqueras M; Ribal MJ; Leibar-Tamayo A; Romero-Otero J; Alcaraz A
Scand J Urol; 2013 Aug; 47(4):282-9. PubMed ID: 23181478
[TBL] [Abstract][Full Text] [Related]
11. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
12. Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.
Porcaro AB; Novella G; Cacciamani G; De Marchi D; Corsi P; De Luyk N; Bizzotto L; Processali T; Cerasuolo M; Tamanini I; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 98(1):22-27. PubMed ID: 27376763
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BSh; Ng AT; Ma WK; Ho KL; Yiu MK
Asian J Androl; 2015; 17(5):821-5. PubMed ID: 25652619
[TBL] [Abstract][Full Text] [Related]
14. Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study.
Porcaro AB; Novella G; Balzarro M; Martignoni G; Brunelli M; Cacciamani G; Cerruto MA; Artibani W
Asian J Urol; 2015 Oct; 2(4):224-232. PubMed ID: 29264150
[TBL] [Abstract][Full Text] [Related]
15. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
[TBL] [Abstract][Full Text] [Related]
16. Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.
Porcaro AB; Novella G; Mattevi D; Bizzotto L; Cacciamani G; Luyk ND; Tamanini I; Cerruto MA; Brunelli M; Artibani W
Curr Urol; 2016 May; 9(2):82-92. PubMed ID: 27390581
[TBL] [Abstract][Full Text] [Related]
17. Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.
Chiu PK; Roobol MJ; Teoh JY; Lee WM; Yip SY; Hou SM; Bangma CH; Ng CF
Int Urol Nephrol; 2016 Oct; 48(10):1631-7. PubMed ID: 27349564
[TBL] [Abstract][Full Text] [Related]
18. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
[TBL] [Abstract][Full Text] [Related]
19. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
[TBL] [Abstract][Full Text] [Related]
20. Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
Wolters T; Roobol MJ; Bangma CH; Schröder FH
Eur Urol; 2009 Feb; 55(2):385-92. PubMed ID: 18353529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
